跳至主要内容
临床试验/JPRN-UMIN000004512
JPRN-UMIN000004512招募中未知

A prospetctive observational study to elucidate the safty and efficacy of GLP-1 analogue treatment for non-alcoholic steatohepatitis patients with type2 diabetes mellitus - NASH DM GLP-1 study

Mitsui Memorial Hospital0 个研究点目标入组 20 人开始时间: 2010年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patinets who have history of HBV or HCV infection, and auto-immune hepatitis. 2.Patients who take alcohol more than 20g/day as 100% ethanol. 3.Patients who have renal dysfunction (Cre over 2.0 mg/dl or eGFR less than 30 mL/min). 4.Patients who have platelet counts less than 50,000/micro-litter or prothrombin activity less than 50%. 5.Patients who have history of pancreatitis. 6.Patients who are treated with other clinical trial medicine. 7.Patients who have malignancy. 8.Patients who are judged no indication by whome resposible for this study.

研究者

相似试验